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Abstract
Background: Family and pregnancy planning issues are important among human immunodeficiency virus
(HIV)-positive individuals and couples. However, access to fertility services may be limited for this population.
The objective of this study was to estimate the types of services available in fertility clinics in Canada for
these individuals.
Methods: A survey was sent to all registered fertility clinics in Canada to assess the availability of services
(investigations and treatment) for infertility and/or viral transmission risk reduction in achieving pregnancy. The
proportion and location of clinics willing to carry out investigations and treatments were determined. Logistic
regression analysis was performed to assess differences in response rates, investigations, and treatments by
province and by couple scenario.
Results: Completed surveys were received from 23/28 (82%) of clinics across eight Canadian provinces. Seventy-
eight per cent (18/23) were willing to accept HIV-positive individuals in consultation, and 52% had actually seen at
least one HIV-positive man or woman in the previous year. Clinics in every province were willing to offer infertility
investigations, but only clinics located in five provinces were willing to offer fertility treatments. The most
commonly available treatment was intrauterine insemination for couples in which the female partner was HIV-
positive (52%). Other techniques, such as sperm washing (26%) or in vitro fertilization (17%), were less commonly
offered. A smaller number of clinics were willing to offer risk reduction techniques in achieving pregnancy.
Conclusions: Access to infertility investigations and treatments in Canada is limited and regionally dependent.
Trial Registration: Registered with ClinicalTrials.gov at http://www.clinicaltrials.gov, registration number
NCT00782132.
Background
Since the identification of the human immunodeficiency
virus (HIV) and the acquired immunodeficiency syn-
drome (AIDS) in the 1980s, there have been significant
advances made in the management and long-term prog-
nosis for infected individuals. In the early days of the
epidemic, most people diagnosed as HIV-positive were
not expected to live a long lifespan. Currently, with the
advent of combination antiretroviral therapy (cART),
and the ability to reconstitute the immune system and
keep viral loads to undetectable levels, HIV-positive
individuals may live a healthy and productive life for
years to decades after diagnosis. With this progress,
family and pregnancy planning issues have become
important for HIV-positive men and women.
Worldwide, it is estimated that 33.2 million people are
infected with HIV. In Canada, women accounted for
27.8% of positive HIV tests in 2006 [1]. Among these
women, at least 70% were of childbearing age [2]. Simi-
larly, most HIV-positive men are fertile and have the
potential to have children.
Living with HIV/AIDS may modify, but does not
appear to remove the wish to have children. Several stu-
dies performed worldwide have documented that a sub-
stantial proportion of HIV-positive men and women
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have expressed the desire or intention to have children
[3-5]. As life expectancy among patients infected with
HIV has increased, there has been a need to allow this
group of people to have access to advanced reproductive
technologies and fertility treatments. Since the early
years of the HIV epidemic, the treatment of fertility
issues in couples in which one or both partners was
HIV-positive has been controversial. However, more
recently it has been argued that it is unethical to with-
hold fertility services to these individuals or couples
[6-8]. Despite good evidence for the safety and efficacy
of advanced reproductive technologies in HIV-infected
couples [9-12], access to clinics providing these services
may be limited. Barriers to access include not only ethi-
cal issues, but also technical difficulties related to the
handling of specimens and training of staff. In both the
United Kingdom and Australia, studies have been per-
formed to evaluate the accessibility of fertility services
for HIV-infected couples [13,14]. The results of these
studies were disappointing, with limited access for both
investigations and treatments.
The primary objective of this study was to determine
the proportion and location of fertility clinics in
Canada that would provide advanced reproductive
technologies to HIV-infected individuals and couples.
The secondary objectives were to determine how many
clinics would provide specific services for infertility or
for viral transmission risk reduction strategies to
achieve pregnancy.
Methods
Prior to initiation of the study, approval was obtained
from the hospital Research Ethics Board. To assess
available services, a questionnaire was sent to fertility
clinics across Canada (Appendix A). This questionnaire
was based on those used in the United Kingdom and
Australia studies, as there was no other validated survey
instrument available [13,14]. Prior to study initiation,
study authors and other physicians reviewed versions of
the questionnaire for face validity, and changes were
incorporated for content validity and clarity. The final
version was five pages long and contained 25 questions.
Most questions were in yes/no format and assessed the
availability of services (investigations and treatments) for
HIV-positive men and women for infertility and/or viral
transmission risk reduction in achieving pregnancy.
A list of all fertility clinics in Canada was compiled
from the Canadian Fertility and Andrology Society. An
introductory email was sent in November 2007 to the
Medical or Laboratory Director of each clinic explaining
the study and asking for participation. If the clinic
agreed to participate, the survey was emailed. Respon-
dents were permitted to return completed surveys by
email or fax. Non-responders were re-contacted three
times by email, and then by fax.
A sample size of convenience was used for this study
as all clinics registered with the Canadian Fertility and
Andrology Society were included. Completed question-
naires were sent to one of the authors (MY) and data
was entered into an Excel spread sheet. The statistical
analysis consisted mainly of summary statistics to report
on the proportion and location of clinics willing to carry
out infertility investigations and treatments for HIV-
positive individuals and couples. Finally, we assessed
how many clinics had specific policies relating to the
investigations and/or treatments of HIV-positive indivi-
duals and couples. Using SAS 9.1, logistic regression
analysis was performed to assess differences in response
rates, investigations, and treatments by province and by
couple scenario.
Results
There were 28 clinics located across eight Canadian pro-
vinces. Completed surveys were received from 23/28
clinics, for a response rate of 82%. Table 1 presents the
response rate by province. Using logistic regression ana-
lysis, there were no significant differences in response
rates by province (p > .05).
Of the responding 23 clinics, 18 (78%) were willing to
accept HIV-positive individuals for consultation. When
asked with reference to the couple, 18/23 (78%) clinics
would accept couples in which the female partner was
Table 1 Questionnaire Response Rates by Province
Province Number of Clinics in Province Number of Clinics Responding Response Rate (%)
British Columbia (BC) 4 3 75
Alberta (AB) 1 1 100
Saskatchewan (SK) 1 1 100
Manitoba (MB) 1 1 100
Ontario (ON) 14 12 86
Quebec (QC) 5 3 60
New Brunswick (NB) 1 1 100
Nova Scotia (NS) 1 1 100
Total 28 23 82
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HIV-positive, 17/23 (74%) would accept couples in
which the male partner was HIV-positive, and 17/23
(74%) would accept couples in which both partners
were HIV-positive for consultation.
Although greater than 70% of clinics were willing to
see HIV-positive individuals or couples in consultation,
substantially less had actually seen any HIV-positive
men (11/23, 48%) or women (10/23, 43%) in the pre-
vious 12 months. Of those who answered, 12 clinics sta-
ted that these individuals were seeking care for fertility
problems and 7 stated that they were seeking strategies
for risk reduction in achieving pregnancy (reducing the
risk of sexual transmission to either partner while
achieving pregnancy).
Regarding services offered, there was regional varia-
tion, with clinics in every province offering infertility
investigations but only clinics located in five provinces
offering fertility treatments if either or both partners
were HIV-positive. A smaller number of clinics were
willing to offer risk reduction techniques in achieving
pregnancy. Table 2 presents the services available
based on province. For couples in which the male part-
ner was HIV-positive and the female partner HIV-
negative, 17/23 (74%) clinics would offer investigations,
12/23 (52%) would offer fertility treatments, and 10/23
(43%) would offer risk reduction techniques. The num-
bers were very similar for couples in which the female
partner was HIV-positive and the male partner HIV-
negative, with 16/23 (70%) clinics offering investiga-
tions, 11/23 (48%) offering fertility treatments, and 10/
23 (43%) offering risk reduction techniques. If both
partners were HIV-positive, access decreased, with 15/
23 (65%) clinics offering investigations, 8/23 (35%)
offering fertility treatments, and 6/23 (26%) offering
risk reduction techniques. Using logistic regression, we
analyzed the likelihood of being offered investigations,
treatments, or risk reduction techniques based on
which partner was HIV-positive (Table 3). There were
no statistically significant differences in these likeli-
hoods regardless of whether the male partner, female
partner, or both partners were HIV-positive (p > .05
for all comparisons).
With respect to specific advanced reproductive tech-
nologies available, the most commonly available tech-
nique was intrauterine insemination (IUI) for couples
in which the female partner was HIV-positive, with 12/
23 (52%) providing this service (at least one clinic in
seven out of eight provinces). Other procedures were
less commonly available, with sperm washing for cou-
ples in which the male partner was HIV-positive
offered in only 6/23 (26%) clinics in four provinces
and in vitro fertilization (IVF) for couples in which the
female partner was HIV-positive offered in only 4/23
(17%) clinics in two provinces. Eight clinics (35%)
reported being able to offer any combination of tech-
nologies for HIV-infected couples. Finally, 12/23 (52%)
clinics (at least one clinic in seven out of eight pro-
vinces) were willing to offer donor sperm to single
HIV-positive women.
In addition to assessing clinic experience with and
willingness to provide services for HIV-positive indivi-
duals and couples, there were also questions in the sur-
vey about clinic policies with respect to potentially
infected specimens. Only 5/23 (22%) clinics in two pro-
vinces had written policies regarding the investigations
of HIV-positive individuals, but 16/23 (70%) had policies
governing treatment. A very small proportion of clinics
used separate times of the day or week (3/23, 13%) or
had separate facilities (2/23, 9%) to handle potentially
contaminated specimens.
Table 2 Services Available Provincially for HIV-Positive Individuals
Province (N = 23) Infertility Investigations Offered Infertility Treatments Offered Risk Reduction Techniques Offered
BC (N = 3) Yes No No
AB (N = 1) Yes Yes Yes
SK (N = 1) Yes Yes Yes
MB (N = 1) Yes Yes No
ON (N = 12) Yes Yes Yes
QC (N = 3) Yes No No
NB (N = 1) Yes No No
NS (N = 1) Yes Yes Yes
Table 3 Differences in Investigation and Treatment Rates Based on HIV Status
Male HIV+/Female HIV- Male HIV-/Female HIV+ Male HIV+/Female HIV+ P value
Infertility investigations offered (%) 74 70 65 0.82
Infertility treatments offered (%) 52 48 35 0.47
Risk reduction techniques offered (%) 43 43 26 0.38
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Discussion
In this national survey of fertility clinics carried out
across Canada, access to infertility investigations and
treatments was limited for HIV-positive men and
women, and was regionally dependent. While greater
than 70 per cent of clinics reported being willing to see
HIV-positive individuals, only approximately half had
actually seen any in the previous 12 months. Roughly 50
per cent of clinics offered fertility treatments to this
group of individuals, with the most commonly available
being IUI. Access to sperm washing and IVF was much
more limited.
As life expectancy among HIV-positive people has
increased, fertility desires and pregnancy planning have
emerged as important issues in this community. Arising
from this is a need to facilitate access to advanced
reproductive technologies and fertility treatments. Two
broad groups of patients are likely to request these
options. The first group consists of couples in which
only one partner is infected with HIV (serodiscordant
couples) who would like to have children but who wish
to avoid the risk of transmission to the uninfected part-
ner. These couples may or may not be subfertile. The
second group consists of serodiscordant couples who
are subfertile and have tried to conceive spontaneously
without success, subfertile couples in which both part-
ners are infected, same-sex couples, and single HIV-
positive men and women wishing to have children.
Since the early years of the HIV epidemic, the treat-
ment of fertility issues in couples in which one or both
partners was HIV-positive has been controversial. Major
issues included the possibility of mother-to-child trans-
mission and the likelihood that the parent(s) might die
before the child reached adulthood. Both of these issues
have become less of a problem in recent years. HIV-
positive individuals now have aggressive treatment
options available to them which have resulted in dra-
matic declines in mortality. Furthermore, advances in the
management of HIV in pregnancy have decreased rates
of mother-to-child transmission to very low levels. In one
of the first randomized placebo-controlled trials in preg-
nant women, the use of zidovudine monotherapy in preg-
nancy, during labor and delivery, and postpartum to the
infant, resulted in a drop in transmission rates from
25.5% with no treatment to 8.3% in the treatment group
[15]. Subsequent studies have shown that in the setting
of cART and an undetectable viral load, transmission
rates are as low as 1% to 2% or less [16-18].
With these favorable statistics, it has been argued that
it is unethical to withhold fertility care and/or assisted
reproductive technologies to couples in which one or
both partners is HIV-positive [6-8]. There are many
other serious and potentially fatal diseases affecting
women in their reproductive years, and fertility treat-
ments are rarely refused in these cases. Conditions such
as longstanding insulin-dependent diabetes mellitus or
lupus nephritis have been cited as examples in which
the long-term health of the mother may be at higher
risk than with HIV [7]. Similarly, there are conditions
such as Tay-Sachs disease in which the risk of transfer
to children is approximately the same as HIV infection
even before interventions that lowered this rate. Couples
with these risks are often still encouraged to consider
pregnancy, and not denied access to assisted reproduc-
tive technologies. Denying HIV-positive individuals and
couples the opportunities for fertility counseling and
treatments may lead them to distance themselves from
the medical community, and to engage in behavior that
puts one or both partners at risk [19,20]. The results of
our survey revealed that the majority of clinics in
Canada (78%) were willing to see HIV-positive indivi-
duals in consultation, although only 48% had actually
seen an HIV-positive man and 43% had actually seen an
HIV-positive woman in the preceding 12 months. Some
clinics in smaller communities reported that although
they were willing to see HIV-positive men and women,
they were not able to offer investigations or treatments,
so they encouraged these individuals to be seen in more
urban areas in adjacent provinces.
In a couple where the female partner is infected and
the male partner is not, there are two commonly
employed strategies used to achieve a pregnancy. The
first is to have unprotected intercourse, which places the
male partner at risk of seroconversion. The second is to
use self-insemination techniques at home, which have
variable success rates. Couples who fail to conceive in
this way may require more formal assistance with
options such as cycle monitoring to use timed insemina-
tion, IUI or IVF. Our results showed that IUI was the
most commonly available technique in Canada, with
52% of responding clinics offering this service to couples
in which the female partner was HIV-positive (at least
one clinic in seven out of eight provinces).
In a couple where the male partner is infected and the
female partner is not, she is at risk of acquiring HIV
infection if they try to achieve pregnancy through
unprotected intercourse, with an approximate risk of
0.1% to 0.2% per unprotected act [21]. In a series of 104
pregnancies achieved through natural conception in
HIV-positive men with HIV-negative women partners,
no seroconversions occurred within the first three
months following conception, but two women serocon-
verted at seven months of pregnancy and two others
converted postpartum [22]. This study was performed
before viral load testing was available, so viral load sta-
tus of these men is not known. However, it has been
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shown that blood and genital tract viral loads may not
correlate well, so even a low blood viral load may not
translate into low semen viral loads [23]. A safer alter-
native is the use of sperm washing techniques which
separate actual spermatozoa from seminal fluid, which
harbors the virus. Sperm itself does not express signifi-
cant levels of HIV receptors, so it is unlikely to be a
major target of HIV infection [23]. To date, 300 healthy
children have been born after more than 3,000 cycles of
sperm washing and IUI or IVF, with no reported sero-
conversions in either partner or children [9-12]. Most
reported cycles are from Europe, with only a small num-
ber from the United States, and no published Canadian
series. In our survey, access to sperm washing and IVF
was very limited, with these technologies only available
in a small number of clinics. Six clinics (26%) in four
provinces offered sperm washing, and only four clinics
(17%) in two provinces offered IVF.
In a couple where both partners are infected, avoid-
ance of unprotected intercourse is still advised, to pre-
vent potential transmission of more aggressive virus
between partners. These couples also may benefit from
fertility services.
In every province, there were more clinics willing to
offer investigations than treatments to HIV-positive
individuals. According to respondents, this does not
reflect a lack of willingness to treat HIV-positive people,
but reflects the technical difficulties with the handling of
potentially infected specimens and training of staff.
Although there is good evidence for the safety and effi-
cacy of advanced reproductive technologies in HIV-
infected couples, access to clinics providing these
services in Canada is limited. The safest way to offer
these services may be to separate HIV-infected patients
in either time and/or space from HIV-negative indivi-
duals [18,19]. Some clinics have even built separate
laboratories with separate equipment to achieve this goal
[19]. A very small proportion of clinics in Canada have
adopted these policies, with 3/23 (13%) using separate
times of the day or week and 2/23 (9%) having separate
facilities to handle potentially contaminated specimens.
Survey respondents replied that this was an expensive
and logistically difficult strategy to put into practice.
For all combinations of couples, more clinics offered
fertility treatments than risk reduction techniques in
achieving pregnancy. This finding is interesting, and
may indicate a greater willingness among clinics to
intervene in cases where there are fertility problems (for
example, blocked fallopian tubes or low sperm counts)
compared with couples for whom fertility is not a pro-
blem, but who are seeking safer methods to become
pregnant. Future research should focus on this aspect of
access to care for couples in which one or both partners
is HIV-positive.
In both the United Kingdom and Australia, studies
similar to this one have been performed to evaluate
the accessibility of fertility services for HIV-infected
couples [13,14]. Each of these were national surveys of
all clinics in the country. In the United Kingdom, the
study was performed in 2001 and 57/75 (76%) of
clinics responded [13]. Only 39% of clinics had seen an
HIV-positive individual in the previous year (48% and
43% for men and women, respectively, in our study). If
the male partner was HIV-positive, 58% of clinics
would offer investigations and 44% would offer treat-
ment (74% and 52% in our study). If the female part-
ner was HIV-positive, 44% would offer investigations
and 25% would offer treatment (70% and 48% in our
study). In Australia, the study was performed in 2002
and 31/52 (60%) of clinics responded [14]. Only 45%
of clinics had seen an HIV-positive man or woman in
the preceding 12 months. With respect to investiga-
tions, 28/31 clinics stated they were willing to offer
investigations. If the male partner was HIV-positive
87% would offer treatment, and 77% would offer treat-
ment if the female partner was HIV-positive. However,
between one-quarter and one-third stated there were
certain specific treatments that would not be offered.
Further, there was no breakdown in either study as to
specifically which treatments would or would not be
offered. The findings of the current study differ from
these studies in some important ways. First, our
response rate is higher, at 82%. Second, our study was
performed several years later, so perhaps attitudes have
changed and access has improved over time. In our
study, more clinics had seen an HIV-positive indivi-
dual. More clinics were willing to offer investigations
and treatments compared to the United Kingdom
study, and less clinics stated that there were treatments
that wouldn’t be offered compared to the Australian
study.
This study has several strengths. It is the first national
survey of fertility clinics in Canada to assess access to
investigations and treatments for HIV-positive men and
women. The response rate of 23/28 (82%) was high,
with only 5/28 clinics not responding. The surveys were
completed by the Medical or Laboratory Directors of
the clinics, and these individuals would be the most
knowledgeable about clinic experience with certain
populations.
There are some limitations to the current study. With
surveys, there is the chance of recall bias, and we had
no way of confirming the responses to our question-
naires. All clinics associated with the Canadian Fertility
and Andrology Society were used for the study, but
there may be other clinics in Canada that are not
affiliated with this organization and therefore were
missed. Finally, we used an unvalidated survey as no
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validated instrument existed, although we did model it
on two previously published surveys and attempted to
validate it ourselves prior to use.
Conclusions
There is a paucity of data available on the types of ser-
vices available for HIV-positive men and women in the
arena of pregnancy planning and infertility. This is an
important area for future investigation and research.
The findings of this study are provocative, and demon-
strate that access to fertility investigations and treat-
ments for HIV-positive individuals is limited in Canada,
and that this access is regionally dependent. Policy
makers and health care professionals caring for these
people should focus on developing strategies to increase
access.
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